Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000889812-97-000396
Filing Date
1997-02-12
Accepted
1997-02-12 00:00:00
Documents
1
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 21838
  Complete submission text file 0000889812-97-000396.txt   23766
Mailing Address 9 DELTA DR LONDONDERRY NH 03053
Business Address 9 DELTA DR LONDONDERRY NH 03053 6034378970
DIATIDE INC (Subject) CIK: 0001011888 (see all company filings)

EIN.: 043078258 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46265 | Film No.: 97526905
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 380 MADISON AVENUE 12TH FLOOR NEW YORK NY 10017
Business Address 380 MADISON AVENUE 12TH FLOOR NEW YORK NY 10017 2126223100
CHASE VENTURE CAPITAL ASSOCIATES L P (Filed by) CIK: 0001015240 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231